We are live on
!
Find out more
NTC
North Tide Capital Portfolio holdings
AUM
$469M
1-Year Est. Return
6.57%
This Fund
S&P 500
This Quarter
Est. Return
-7.93%
1 Year Est. Return
+6.57%
3 Year Est. Return
+14.81%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$897M
AUM Growth
-$26.9M
(-2.9%)
Cap. Flow
+$56.4M
Cap. Flow
% of AUM
6.28%
Top 10 Holdings %
Top 10 Hldgs %
78.53%
Holding
22
New
7
Increased
3
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$70.8M |
| 2 |
Biogen
BIIB
|
+$52.7M |
| 3 |
Perrigo
PRGO
|
+$51.8M |
| 4 |
AGN
Allergan plc
AGN
|
+$34.6M |
| 5 |
QHC
Quorum Health Corporation
QHC
|
+$23.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$56.6M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$53.5M |
| 3 |
Brookdale Senior Living
BKD
|
+$39.3M |
| 4 |
AMED
Amedisys
AMED
|
+$24.2M |
| 5 |
Orthofix Medical
OFIX
|
+$20.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 78.18% |
| 2 | Consumer Discretionary | 5.94% |
Similar funds
SD
DG
NBC
JWM
JPCCM
MCL
GIIO
FC
North Tide Capital's Q2 2016 Portfolio in Review
As of Q2 2016, North Tide Capital held 22 positions worth $897M, down 2.9% from $924M the previous quarter. Its ten largest holdings account for 79% of the portfolio.
North Tide Capital deployed $56.4M of net new capital in Q2 2016, opening 7 new positions and adding to 3 existing holdings. Its largest new stake was Bausch Health: 2,500,000 shares worth $50.4M.
By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 77% a quarter earlier, followed by Consumer Discretionary.
On the sell side, the largest reduction was Community Health Systems, an estimated $56.6M trimmed.
- North Tide Capital's largest Q2 2016 buy was Bausch Health: 2,500,000 shares worth $50.4M.
- North Tide Capital added most to Avanos Medical in Q2 2016, an estimated $7.66M increase.
- North Tide Capital's biggest Q2 2016 reduction was Community Health Systems, cutting an estimated $56.6M.
- North Tide Capital fully exited Teva Pharmaceuticals in Q2 2016, selling an estimated $53.5M.
- North Tide Capital's ten largest holdings make up 79% of its $897M portfolio in Q2 2016.
- North Tide Capital opened 7 new positions and closed 4 in Q2 2016.
- North Tide Capital's portfolio value fell 2.9% quarter-over-quarter to $897M.
Based on North Tide Capital's 13F filing for Q2 2016, filed 15 Aug 2016.